Triple negative breast cancer (TNBC) cells exhibit robust expression of CD24, suggesting that the inducible model described here mimics what is observed in human TNBC and may present a potential therapeutic opportunity for some SOX11+ breast cancers (Barkal et al., 2019). Here, CD24 is linked to breast carcinoma.